Probiotics and antibiotic associated diarrhoea

BMJ 2002; 325 doi: 10.1136/bmj.325.7369.901/b (Published 19 October 2002)
Cite this as: BMJ 2002;325:901.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Lactulose is effective

  1. Mark Battle, specialist registrar.,
  2. Lara Teare, senior house officer.,
  3. Sue Law, preregistration house officer.,
  4. Jamie Fulton, consultant. (jamie.fulton@phnt.swest.nhs.uk)
  1. Directorate of Medicine, Derriford Hospital, Plymouth PL6 8DH
  2. Derriford Hospital, Plymouth PL6 8DH
  3. Care of the Elderly Section, Imperial College Faculty of Medicine, Hammersmith Hospital, London W12 0NN

    EDITOR—D'Souza et al evaluated potential agents for the prevention of antibiotic associated diarrhoea, whose full spectrum of activity is immense both in the community and in hospital.1 In particular, the antitherapeutic default selection of Clostridium difficilewith resultant colitis is associated with a considerable morbidity and mortality.

    Alteration of the faecal flora is attractive as a low risk means of preventing or, possibly, treating C difficileand associated infections.2 Induced disequilibrium of the colonic flora can be achieved either through supplemental probiotic loading or by therapeutic manipulation. Faecal flora can be manipulated through the use of lactulose, a synthetic disaccharide that is predominantly used as an osmotic laxative. It is neither absorbed nor metabolised in the upper gastrointestinal tract but is degraded by the bacterial flora of the proximal colon to organic acids. These acidify the proximal colon and result in a dose dependent catharsis.

    Lactulose has several additional properties, including an antiendotoxin effect and alteration of faecal floral patterns.3 This quantitative alteration in faecal floral patterns, with an increase in faecal Lactobacillus acidophilus and a reduction in both coliforms and bacteroides, has been confirmed in our own unpublished work. A qualitative alteration in bacterial pathogenicity may result with lactulose as an alternative substrate.

    Additional historical evidence shows effective treatment of shigellosis and salmonellosis with lactulose.45 Several …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL